Dose-Escalating (50-500 mg) Gluten Administration Leads to Detectable Gluten-Immunogenic-Peptides in Urine of Patients with Coeliac Disease Which Is Unrelated to Symptoms, a Placebo Controlled Trial.
Saved in:
| Title: | Dose-Escalating (50-500 mg) Gluten Administration Leads to Detectable Gluten-Immunogenic-Peptides in Urine of Patients with Coeliac Disease Which Is Unrelated to Symptoms, a Placebo Controlled Trial. |
|---|---|
| Authors: | Burger JPW; Department of Gastroenterology and Hepatology, Rijnstate Hospital, 6815 AD Arnhem, The Netherlands., van Lochem EG; Department of Microbiology and Immunology, Rijnstate Hospital, 6815 AD Arnhem, The Netherlands., Roovers EA; Department of Clinical Research, Rijnstate Hospital, 6815 AD Arnhem, The Netherlands., Drenth JPH; Department of Gastroenterology and Hepatology, RadboudUMC, 6525 GA Nijmegen, The Netherlands., Wahab PJ; Department of Gastroenterology and Hepatology, Rijnstate Hospital, 6815 AD Arnhem, The Netherlands. |
| Source: | Nutrients [Nutrients] 2022 Apr 23; Vol. 14 (9). Date of Electronic Publication: 2022 Apr 23. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6643 (Electronic) Linking ISSN: 20726643 NLM ISO Abbreviation: Nutrients Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2072-6643 |
|---|---|
| DOI: | 10.3390/nu14091771 |
